Literature DB >> 8164002

British Isles survey of multiple sclerosis in twins: MRI.

J W Thorpe1, C J Mumford, D A Compston, B E Kendall, D G MacManus, W I McDonald, D H Miller.   

Abstract

64/105 subjects who have a twin with multiple sclerosis included in a study of clinical concordance also underwent MRI of the brain. 8/23 monozygotic and 1/41 dizygotic co-twins from this subgroup were clinically concordant of whom 8/9 had MRI appearances typical of multiple sclerosis. Of the 48 clinically discordant twins aged less than 60, abnormalities on MRI were detected in 6/15 (40%) monozygotic and 13/33 (39%) dizygotic twins compared with 7/37 (19%) healthy age-matched controls. Abnormalities on MRI typical of multiple sclerosis (defined by the Fazekas criteria) were, however, present in only 2/15 (13%) monozygotic and 3/33 (9%) dizygotic twins and 0/37 controls. These results suggest that about 10% of monozygotic and dizygotic twins have "subclinical multiple sclerosis". It is likely that most of the MRI abnormalities seen in clinically discordant twins, however, represent incidental pathology.

Entities:  

Mesh:

Year:  1994        PMID: 8164002      PMCID: PMC1072882          DOI: 10.1136/jnnp.57.4.491

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  47 in total

1.  Microinfarction in classic migraine? A study with magnetic resonance imaging findings.

Authors:  A Ferbert; D Busse; A Thron
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

2.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.

Authors:  F Fazekas; H Offenbacher; S Fuchs; R Schmidt; K Niederkorn; S Horner; H Lechner
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

3.  Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates.

Authors:  F Fazekas
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

4.  Leukoencephalopathy in normal and pathologic aging: 2. MRI of brain lucencies.

Authors:  A E George; M J de Leon; A Kalnin; L Rosner; A Goodgold; N Chase
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jul-Aug       Impact factor: 3.825

5.  MRI periventricular lesions in adults.

Authors:  G Gerard; L A Weisberg
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

6.  MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis.

Authors:  D H Miller; I E Ormerod; A Gibson; E P du Boulay; P Rudge; W I McDonald
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

7.  A population-based study of multiple sclerosis in twins: update.

Authors:  A D Sadovnick; H Armstrong; G P Rice; D Bulman; L Hashimoto; D W Paty; S A Hashimoto; S Warren; W Hader; T J Murray
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

8.  Evoked potential testing in relatives of multiple sclerosis patients.

Authors:  M R Nuwer; B R Visscher; J W Packwood; N S Namerow
Journal:  Ann Neurol       Date:  1985-07       Impact factor: 10.422

9.  Subclinical multiple sclerosis.

Authors:  M Morariu; W F Klutzow
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

10.  Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: a comparative study.

Authors:  J R Cutler; M J Aminoff; M Brant-Zawadzki
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

View more
  6 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 2.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.

Authors:  Małgorzata Siger-Zajdel; Krzysztof W Selmaj
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

4.  Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.

Authors:  Cathy J Jensen; Jim Stankovich; Anneke Van der Walt; Melanie Bahlo; Bruce V Taylor; Ingrid A F van der Mei; Simon J Foote; Trevor J Kilpatrick; Laura J Johnson; Ella Wilkins; Judith Field; Patrick Danoy; Matthew A Brown; Justin P Rubio; Helmut Butzkueven
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

5.  Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies.

Authors:  S P Morrissey; F X Borruat; D H Miller; I F Moseley; M G Sweeney; G G Govan; M A Kelly; D A Francis; A E Harding; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 6.  Unanticipated demyelinating pathology of the CNS.

Authors:  Darin T Okuda
Journal:  Nat Rev Neurol       Date:  2009-10-06       Impact factor: 42.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.